The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 20, 2024
Filed:
Aug. 21, 2019
Applicant:
Newave Pharmaceutical Inc., Pleasanton, CA (US);
Inventor:
Yi Chen, Pleasanton, CA (US);
Assignee:
Newave Pharmaceutical Inc., Pleasanton, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/14 (2006.01); C07D 491/147 (2006.01); C07D 519/00 (2006.01); C07D 498/14 (2006.01); C07D 498/22 (2006.01); A61K 31/553 (2006.01); A61K 47/68 (2017.01); A61P 35/02 (2006.01); A61K 33/243 (2019.01); A61K 31/282 (2006.01); A61K 31/4184 (2006.01); A61K 31/4745 (2006.01); A61K 31/4985 (2006.01); A61K 31/519 (2006.01); A61K 31/52 (2006.01); A61K 31/635 (2006.01); A61K 31/7048 (2006.01); A61K 35/17 (2015.01); A61K 38/07 (2006.01); A61K 39/395 (2006.01); C07D 513/14 (2006.01); C07D 515/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/553 (2013.01); A61K 31/282 (2013.01); A61K 31/4184 (2013.01); A61K 31/4745 (2013.01); A61K 31/4985 (2013.01); A61K 31/519 (2013.01); A61K 31/52 (2013.01); A61K 31/635 (2013.01); A61K 31/7048 (2013.01); A61K 33/243 (2019.01); A61K 35/17 (2013.01); A61K 38/07 (2013.01); A61K 39/3955 (2013.01); A61K 47/6849 (2017.08); A61P 35/02 (2018.01); C07D 471/14 (2013.01); C07D 491/147 (2013.01); C07D 498/14 (2013.01); C07D 498/22 (2013.01); C07D 513/14 (2013.01); C07D 515/14 (2013.01); C07D 519/00 (2013.01);
Abstract
The disclosure includes compounds of Formula (A), wherein R, R, R, R, R, R, R, R, R, R, and R, h, j, m, n, k, v, s, g, V, W, L, Z, Q, Q, Q, Q, Q, Q, and Q, are defined herein. Also disclosed is a method for treating a neoplastic disease, an autoimmune disease, or a neorodegenerative disease with these compounds.